Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Viral hepatitis in children with renal disease

  • 33 Accesses

  • 2 Citations

Abstract

Specific and sensitive diagnostic tests are now available to identify type A, B, C, D and E hepatitis. Hepatitis A and E which cause only acute, very rarely fulminant, hepatitis are spread largely by the faecal-oral route, having a brief viraemic phase. Hepatitis B, C and D which are transmitted parenterally and via secretions are often associated with chronic viraemia. Patients with chronic renal disease are at particular risk. Impaired immunity due to disease of drugs increases the propensity to develop a chronic carrier state which may progress to cirrhosis and hepatocellular carcinoma. Limited reports indicate that hepatitis C infection may cause cirrhosis more rapidly than hepatitis B. The emergence of mutants to both hepatitis B and C is a cause for concern. Treatment with interferon is of limited efficacy. Screening of blood products for viral markers and prudent handling of potentially infected materials to avoid contamination of damaged skin or mucous membrane are the best strategies to prevent infection. Hepatitis B vaccination of all newborns, young adolescents and those at risk is the most effective means of reducing the carrier frequency.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Gregorio GV, Mieli-Vergani G, Mowat AP (1993) Neonatal and paediatric infection. In: Zuckermann A, Howard HC (eds) Viral hepatitis scientific basis and clinical management. Churchill-Livingstone, London, pp 541–564

  2. 2.

    Chen D-S (1993) Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol 8: 470–475

  3. 3.

    Mowat AP (1994) Viral infections of the liver. In: Mowat AP (ed) Liver disorders in childhood, 3rd edn. Butterworth, Oxford, pp 97–137

  4. 4.

    Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik C, Suntayakorn S, Suknuntapong T, Safary A, Tang D, Boslego JW (1994) Protection against hepatitis A by an inactivated vaccine. The VI Asian-Pacific Congress of Digestive Endoscopy. Recent developments in immunisation against hepatitis A. 29 Nov–3 Dec, 1992 (in press)

  5. 5.

    Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G, Ryan J, Provost P, Nalin D (1992) A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 327: 453–457

  6. 6.

    Goidsmith R, Yarbough PO, Reyes GR, Fry KE, Gabor KA, Kamel M, Zakaria S, Amer S, Gaffar Y (1992) Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 339: 328–331

  7. 7.

    Hyams KC, Purdy MA, Kaur M, McCarthy MC, Hussain MAM, El-Tigani A, Krawczynski K, Bradley DW, Carl M (1992) Acute sporadic hepatitis E in Sudanese children: analysis based on a new Western blot assay. J Infect Dis 165: 1001–1005

  8. 8.

    Pillot J, Lazizi Y, Diallo Y, Leguenno B (1992) Frequent sporadic hepatitis E in West Africa as evidenced by characterization of a virus associated antigen in stool. J Hepatol 15: 420–421

  9. 9.

    Sallie R, Chiyende J, Tan KC, Bradley D, Portmann B, Williams R, Mowat AP, Mieli-Vergani G (1994) Fulminant hepatic failure due to co-existent Wilson's disease and hepatitis E. Gut 35: 849–853

  10. 10.

    Rosenblum LS, Villarino ME, Nainan OV, Melish ME, Hadler SC, Pinsky PP, Jarvis WR, Ott CE, Margolis HS (1991) Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 164: 476–482

  11. 11.

    Fagan E, Yousef G, Brahm J, Garelick H, Mann G, Wolstenholme A, Portmann B, Harrison T, Mowbray JF, Mowat A, Zuckerman A, Williams R (1990) Persistence of hepatitis A virus in fulminant hepatitis and after liver transplantation. J Med Virol 30: 131–136

  12. 12.

    Hollinger FB, Lemon SM, Margolis HS (1991) Viral hepatitis and liver disease. Williams and Wilkins, Baltimore, pp 135–148

  13. 13.

    Carman WF, Zanetti AR, Karayannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet II: 325–329

  14. 14.

    Carman WF, Thomas HC (1992) Genetic variation in hepatitis B virus. Gastroenterology 102: 711–719

  15. 15.

    Kosaka Y, Takase K, Kojima M, Shimizu M, Inque K, Yoshiba M, Tanake S, Akahane Y, Okanoto H, Tsuda F, Miyakawa Y, Mayumi M (1991) Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 100: 1087–1094

  16. 16.

    Terazawa S, Kojima M, Yamanaka T, Yotsumoto S, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M (1991) Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen. Pediatr Res 29: 5–9

  17. 17.

    Bortolitti F, Cadrobbi P, Crivellaro C, Guido M, Rugge M, Noventa F, Calzia R, Realdi G (1990) Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 99: 805–810

  18. 18.

    Fong TL, Di Bisceglie M, Gerber MA, Waggoner JG, Hoofnagle JH (1993) Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 18: 1313–1318

  19. 19.

    Abb J, Zachoval R, Eisenburg J, Pape GR, Zachoval U, Deinhardt F (1985) Production of interferon alpha and interferon gamma by peripheral leukocytes from patients with chronic hepatitis B virus infection. J Med Virol 16: 171–176

  20. 20.

    Bortolotti F, Calzia R, Cadrobbi P, Giacchini R, Ciravegna B, Armigliato M, Piscopa R, Realdi G (1986) Liver cirrhosis associated with chronic hepatitis B virus infection in childhood. J Pediatr 198: 224–227

  21. 21.

    Chang MH, Sung JL, Lee CY, Chen CJ, Chen JS, Hsu HY, Lee P, Chen DS (1989) Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr 115: 385–390

  22. 22.

    Chu CM, Karayiannis P, Fowler MJ, Monjardino J, Liaw YF, Thomas HC (1985) Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 5: 431–434

  23. 23.

    Lok ASF, Lai CL (1988) A longitudinal follow-up of asymptomatic hepatitis B surface antigen positive Chinese children. Hepatology 8: 1130–1133

  24. 24.

    Hsu HY, Chang MH, Lee CY, Chen JS, Hsu HC, Chen DS (1992) Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 15: 382–386

  25. 25.

    Bortolotti F, Calzia R, Cadrobbi P, Crivellaro C, Alberti A, Marazzi G (1990) Long-term evolution of chronic hepatitis B in children with antibody to hepatitis B e antigen. J Pediatr 116: 552–555

  26. 26.

    Bortolotti F, Calzia R, Vegnente A, Cadrobbi P, Rugge M, Armigliato M, Marazzi MG, Iorio R, Crivellaro C, Piscopo R, Realdi G (1988) Chronic hepatitis in childhood: the spectrum of the disease. Gut 29: 659–664

  27. 27.

    Ruiz-Moreno M, Camps T, Aguardo JG, Porres JC, Oliva H, Bartolome J, Carreno V (1989) Serological and histological follow up of chronic hepatitis infection. Arch Dis Child 64: 1165–1169

  28. 28.

    Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, Robinson WS, Merigan TC, Gregory PB (1984) Survival in chronic hepatitis B. Ann Intern Med 101: 613–616

  29. 29.

    Hsu HC, Wu MZ, Chang MJ, Su IJ, Chen DS (1987) Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan: a report of 51 cases strongly associated with rapid development of liver cirrhosis. J Hepatol 5: 260–267

  30. 30.

    Leuschner I, Harms D, Schmidt D (1988) The association of hepatocellular carcinoma in childhood with hepatitis B virus infection. Cancer 62: 2363–2369

  31. 31.

    Chen N, Levy M (1991) Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80s. Kidney Int 40: S24-S33

  32. 32.

    Coovadia HM, Adhikari M, Moodley D (1993) Hepatitis B ‘s’ and ‘e’ antigen carriage in childhood nephrotic syndrome predicts membranous glomerulonephritis. Ann Trop Paediatr 13: 79–82

  33. 33.

    Hsu HC, Wu CY, Lin CY, Lin GJ, Chen CH, Huang FY (1989) Membranous nephropathy in 52 hepatitis B surface antigen (HBsAg) carrier children in Taiwan. Kidney Int 36: 1103–1107

  34. 34.

    Wiggelinkhuizen J, Sinclair-Smith C, Stannard LM, Smuts H (1983) Hepatitis B virus associated membranous glomerulonephritis. Arch Dis Child 58: 488–496

  35. 35.

    La-Manna A, Polito C, Foglia AC, Opallo A, Cafaro MR, Di Toro R (1991) Normal response to anti-HBV vaccination in children with chronic renal insufficiency. Child Nephrol Urol 11: 203–205

  36. 36.

    Kleinknecht C, Levy M, Peix A, Broyer M, Courtecuisse V (1979) Membranous glomerulonephritis and hepatitis B surface antigen in children. J Pediatr 95: 946–952

  37. 37.

    Southwest Pediatric Nephrology Study Group (1985) Hepatitis B surface antigenemia in North American children with membranous glomerulonephropathy. J Pediatr 106: 571–578

  38. 38.

    O'Neil JS (1982) Hepatitis B infection in glomerulonephritis. BMJ 284: 52

  39. 39.

    Szmuness W, Prince AM, Grady GF, Mann MK, Levine RW, Friedman EA, Jacobs MJ, Josephson A, Ribot S, Shapiro FL, Stenzel KH, Suki WN, Vyas G (1974) Hepatitis B infection. A point-prevalence study in 15 haemodialysis centers. JAMA 227: 901–906

  40. 40.

    Callis LM, Clanxet J, Fortuny G, Caballeria J, Carrasco JL, Lardinois R (1985) Hepatitis B infection and vaccination in children undergoing hemodialysis. Acta Paediatr Scand 74: 213–218

  41. 41.

    Cadrobbi P, Bortolotti F, Zacchello G, Rinaldi R, Armigliato M, Realdi G (1985) Hepatitis B virus replication in acute glomerulonephritis with chronic active hepatitis. Arch Dis Child 60: 583–585

  42. 42.

    Esteban R, Buti M, Valles M, Allende H, Guardia J (1986) Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate. Hepatology 6: 762–763

  43. 43.

    Slusarczyk J, Michalak T, Mezer T de, Krawczynski K, Nowolawski A (1980) Membranous glomerulopathy associated with hepatitis B core antigen immune complexes in children. Am J Pathol 98: 29–39

  44. 44.

    Bajtai G, Ambrus M, Paal M, Nagy J, Deak G (1975) Hepatitis B antigenemia associated with progressive cirrhosis and membranous glomerulonephritis. Lancet I: 102–103

  45. 45.

    Drachman R (1989) Vaccination against hepatitis B in children and adolescent patients on dialysis. Nephrol Dial Transplant 4: 372–374

  46. 46.

    Pillion G, Chiesa M, Maisin A, Schlegel N, Loirat C (1990) Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure. Pediatr Nephrol 4: 627–629

  47. 47.

    Bruguera M, Cremades M, Rodicio JL, Alcazar JM, Oliver A, Del Rio G, Esteban-Mur R (1989) Immunogenicity of a yeast-derived hepatitis B vaccine in hemodialysis patients. Am J Med 87: 30S-32S

  48. 48.

    Choo QL, Kuo C, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359–362

  49. 49.

    Alberti A (1991) Diagnosis of hepatitis C: facts and perspectives. J Hepatol 12: 279–282

  50. 50.

    Alberti A, Realdi G (1991) Parenterally-acquired non-A, non-B (type C) hepatitis. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J (eds) Oxford textbook of clinical hepatology. Oxford University Press, Oxford, pp 605–617

  51. 51.

    Alter HJ (1992) New kit on the block: evaluation of second generation assays for the detection of antibody to the hepatitis C virus. Hepatology 15: 229–233

  52. 52.

    Sherlock S, Dusheiko G (1991) Hepatitis C virus update. Gut 32: 965–967

  53. 53.

    Kao JH, Chen PJ, Lai MY, Chen DS (1993) Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis. Gastroenterology 105: 583–587

  54. 54.

    Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M, Hayashi Y, Jomori T, Suzuki S (1993) Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-β. Hepatology 18: 1319–1325

  55. 55.

    Marcen R, Gamez C, Mateos ML, Orofino L, Teruel JL, Serrano P, Quereda C, Nash R, Ortuno J (1993) Hepatitis C antibody after kidney transplantation: clinical significance. Am J Nephrol 13: 184–189

  56. 56.

    Chan TM, Lok ASF, Cheng IKP, Ng IOL (1993) Chronic hepatitis C after renal transplantation. Transplantation 56: 1095–1098

  57. 57.

    Huang CS, Ho MS, Yang CS, Lee CL, Tan CA (1993) Hepatitis C markers in haemodialysis patients. J Clin Microbiol 31: 1764–1769

  58. 58.

    Pereira BJG, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ, Wilber JC, Levey AS (1992) Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in recipients of their organs. N Engl J Med 327: 910–915

  59. 59.

    Roth D, Fernandez JA, Babischkin S, De Mattos A, Buck BE, Quan S, Olson L, Burke GW, Nery JR, Esquenazi V, Schiff ER, Miller J (1992) Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease. Ann Intern Med 117: 470–475

  60. 60.

    Kiyasawa K, Sodeyama T, Tanaka E, Shimizu S, Furuta S, Miyasaki Y, Akahane Y, Suzuki H (1991) Intrafamilial transmission of hepatitis C virus in Japan. J Med Virol 33: 114–116

  61. 61.

    Novati R, Thiers V, Monforte AD, Maisonneuve P, Principi N, Conti M, Lazzarin A, Brechot C (1992) Mother-to-child transmission of hepatitis C virus detected by polymerase chain reaction. J Infect Dis 165: 720–723

  62. 62.

    Thaler MM, Park C-K, Landers DV, Wara DW, Houghton M, Veereman-Wauters G, Sweet RL, Han JH (1991) Vertical transmission of hepatitis C virus. Lancet 338: 17–18

  63. 63.

    Weintrub PS, Veereman-Wauters G, Cowan MJ, Thaler MM (1991) Hepatitis C virus infection in infants whose mothers took street drugs intravenously. J Pediatr 119: 869–874

  64. 64.

    Blanchette VS, Vortsman E, Shore A, Wang E, Petric M, Jett BW, Alter HJ (1991) Hepatitis C infection in children with hemophilia A and B. Blood 78: 285–289

  65. 65.

    Locasciulli A, Gornati G, Tagger A, Ribero L, Cavalletto D, Cavaletto L, Masera G, Shulman HM, Portmann B, Alberti A (1991) Hepatitis C virus infection and chronic liver disease in children with leukemia in long term remission. Blood 78: 1619–1622

  66. 66.

    Nigro G, Taliani G, Bartmann U, Vitolo R, Perrone T, Mattia S, Pisano P (1992) Hepatitis in children with thalassemia major. Arch Virol [Suppl] 4: 265–267

  67. 67.

    Jonas MM, Zilleruelo GE, La Rue SI, Abitbol C, Strauss J, Lu Y (1992) Hepatitis C infection in a pediatric dialysis population. Pediatrics 89: 707–709

  68. 68.

    Fink FM, Hocker-Schulz S, Mor W, Puckhammer-Stockl E, Hofmann H, Zoubek A, Pawlowsky J, Hocker P, Gadner H (1993) Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients. Eur J Pediatr 152: 490–492

  69. 69.

    Ngatchu T, Stroffolini T, Rapicetta M, Chionne P, Lantum D, Chiaramonte M (1992) Seroprevalence of anti-HCV in an urban child population: a pilot survey in a developing area, Cameroon. J Trop Med Hyg 95: 57–61

  70. 70.

    Al-Faleh FZ, Ayoola EA, Al-Jeffry M, Al-Rashed R, Al-Mofarreh M, Arif M, Ramia S, Al-Karawi M, Al-Shabrawy M (1991) Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study. Hepatology 14: 215–218

  71. 71.

    Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ, Hahn LC, Choo QL, Wang TH, Houghton M (1991) Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 162: 817–822

  72. 72.

    Hsu SC, Chang MH, Chen DS, Hsu HC, Lee CY (1991) Non-A, non-B hepatitis in children. J Med Virol 35: 1–6

  73. 73.

    Bortolotti F, Vajro P, Cadrobbi P, Lepore L, Zancan L, Barbera C, Crivellaro C, Fontanella A, Alberti A, D'Addezio M (1992) Crytogenic chronic liver disease and hepatitis C virus infection in children. J Hepatol 15: 73–76

  74. 74.

    Hayashi J, Nakashima K, Kajivama W, Noguchi A, Morofuji M, Maeda Y, Kashiwagi S (1991) Prevalence of antibody to hepatitis C virus in hemodialysis patients. Am J Epidemiol 134: 651–657

  75. 75.

    Al-Mugueriren M, Al-Faleh FZ, Ramia S, Al-Rasheed S, Mahmoud MA, Alo-Nasser M (1992) Seropositivity to hepatitis C virus (HCV) in Saudi Arabian children with chronic renal failure maintained on hemodialysis. Ann Trop Paediatr 12: 217–219

  76. 76.

    Stempel CA, Lake J, Kuo G, Vincenti F (1993) Hepatitis C — its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplatation 55: 273–276

  77. 77.

    Chan TM, Lok ASF, Cheng IKP, Chan RT (1993) A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 104: 862–868

  78. 78.

    Takayashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T (1993) Natural course of chronic hepatitis C. Am J Gastroenterol 88: 240–243

  79. 79.

    Alter MJ (1993) The detection, transmission and outcome of hepatitis C virus infection. Infect Agents Dis 2: 155–156

  80. 80.

    Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U, Zauli D, Bianchi F (1990) Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 335: 258–259

  81. 81.

    Ma Y, Peakman M, Lenzi M, Gäken J, Thomas MG, Farzaneh F, Ballardini G, Cassani F, Mieli-Vergani G, Bianchi FB, Vergani D (1993) Case against subclassification of type II autoimmune chronic active hepatitis. Lancet 341: 60

  82. 82.

    Rizzetto M, Durazzo M (1991) Hepatitis delta virus (HDV) infections: epidemiological and clinical heterogeneity. J Hepatol 13: S116-S118

  83. 83.

    Taylor JM, Chao M, Hieh SY, Luo G, Ryo WS (1991) Structure and replication of hepatitis delta virus. In: Hollinger FB, Lemon SM, Margolis HS (eds) Viral hepatitis and liver disease. Williams and Wilkins, Baltimore, pp 460–463

  84. 84.

    Benhamou J-P (1991) Fulminant and subfulminant liver failure: definition and causes. In: Williams R, Hughes RD (eds) Acute liver failure. Mitre, London, pp 6–10

  85. 85.

    Monjardino JP, Saldanha JA (1990) Delta hepatitis: the disease and the virus. Br Med Bull 46: 399–407

  86. 86.

    Perrillo RP (1993) Antiviral therapy of chronic hepatitis B: past, present and future. J Hepatol 17: S56-S63

  87. 87.

    Mondelli M, Mieli-Vergani G, Alberti A, Vergani D, Portmann B, Eddleston ALWF, Williams R (1981) Specificity of T-lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T-cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 129: 2773–2778

  88. 88.

    Ruiz-Moreno M (1993) Chronic hepatitis B in children. Natural history and treatment. J Hepatol 17: S64-S66

  89. 89.

    Ruiz-Moreno M, Rua MJ, Molina J, Moraleda G, Moreno A, Garcia-Aguado J, Carreno V (1991) Prospective randomised controlled trial of interferon-α in children with chronic hepatitis B. Hepatology 13: 1035–1039

  90. 90.

    Lai CL, Lin HJ, Lau JYN, Lok ASE, Wu PC, Chung HT, Wong LSK, Leung MP, Yeung CY (1991) Effect of recombinant alpha-interferon with or without prednisolone in Chinese HBsAg carrier children. Q J Med 78: 155–163

  91. 91.

    Perillo RP, Regenstein FG, Peters MG, DeSchryver-Kecskemeti K, Bodicky CJ, Campbell CR, Kuhns MC (1988) Prednisolone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis a randomized, controlled trial. Ann Intern Med 109: 95–100

  92. 92.

    Vajro P, Orso G, D'Antonio A, Greco L, Fontanella A, Loffredo G, Oggero V, Buffolano W (1985) Inefficacy of immunosuppressive treatment in HBsAg positive, δ-negative moderate chronic active hepatitis in children. J Pediatr Gastroenterol Nutr 4: 26–31

  93. 93.

    Sik-Nin W, Yu ECL, Lok ASF, Kwok-Wah C, Yu-Lung L (1992) Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Pediatr Nephrol 6: 417–420

  94. 94.

    Man RA de, Schalm SW, Heijden AJ van der, Kate FWJ ten, Wolff ED, Heijtink RA (1989) Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy. J Hepatol 8: 367–372

  95. 95.

    Saracco G, Rosina F, Abate ML, Chiandussi L, Gallo V, Cerutti E, Di Napoli A, Solina A, Deplano A, Tocco A, Cossu P, Chien D, Duo G, Polito A, Weiner AJ, Houghton M, Verme G, Bonino F, Rizetto M (1993) Long term follow-up of patients with chronic hepatitis C treated with different doses of interferon α-2b. Hepatology 18: 1300–1305

  96. 96.

    Iorio R, Guida S, Fariello I, Rosa E de, Porzio S, Vegnente A (1992) Alpha lymphoblastoid interferon (α-Ly-IFN) therapy in 12 children with chronic non-A, non-B hepatitis (CNANBH) (7 anti-HCV+). Proceedings of the Second Joint Meeting of the British and Italian Societies of Paediatric Gastroenterology and Nutrition. Harwood, Newmarket, p 65

  97. 97.

    Virgilis S de, Clemente MG, Congia M, Lilliu F, Lampis R, Fray F, Frau MR, Faa G, Diana G, Melis A, Mazzoleni AP, Cornacchia G, Lai ME, Cao A (1992) Recombinant interferon alpha treatment in thalassemia major children with chronic hepatitis C and liver iron overload. Proceedings of the Second Joint Meeting of the British and Italian Societies of Paediatric Gastroenterology and Nutrition. Harwood. Newmarket, p 23

  98. 98.

    Di Marco V, Lo Iacono O, Capra M, Grutta S, Ciaccio C, Gerardi C, Maggio A, Renda D, Almasio P, Pisa R, Craxi A (1992) Alpha-interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia. Haematologica (Pavia) 77: 502–506

  99. 99.

    Uchida T, Taira M, Shikata T, Moriyama M, Tanaka N, Okubo H, Arakawa Y (1993) Histological difference between complete responders and non-responders to interferon therapy of the livers of patients with chronic hepatitis C. Acta Pathol Jpn 43: 230–236

  100. 100.

    Chan TM, Lok ASF, Cheng IKP, Ng IOL (1993) Chronic hepatitis C after renal transplantation. Transplantation 56: 1095–1098

  101. 101.

    Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, Diquattro O, Di Marco V, Loiacono O, Volpes R, Almasio P, Urdea MS, Neuwald P, Sanchez-Pescador R, Detmer J, Wilber JC, Pagliaro L (1994) Hepatitis C viremia in chronic liver disease: relationship to interferon-α or corticosteroid treatment. Hepatology 19: 273–279

Download references

Author information

Correspondence to Alex P. Mowat.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gregorio, G.V., Mowat, A.P. Viral hepatitis in children with renal disease. Pediatr Nephrol 8, 610–619 (1994). https://doi.org/10.1007/BF00858146

Download citation

Key words

  • Hepatitis B
  • Hepatitis C
  • Interferon
  • Post-transfusion hepatitis
  • Hepatitis B-associated membranous glomerulonephritis
  • Renal transplant